This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: University of Miami. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Julie Spielman: Innovator in Cancer Immunotherapy
Introduction
Julie Spielman is a prominent inventor based in Miami, FL (US). She has made significant contributions to the field of cancer immunotherapy through her innovative research and patented inventions. Her work focuses on developing methods to enhance the immune response against cancer and infectious diseases.
Latest Patents
Julie Spielman holds a patent for a groundbreaking invention titled "Recombinant cancer cell secreting modified heat shock protein-antigenic peptide complex." This invention relates to methods for purifying immunogenic complexes of modified heat shock proteins that are noncovalently associated with antigenic peptides of cancer or infected cells. The methods involve constructing a nucleotide sequence encoding a secretable modified heat shock protein, expressing this sequence in an appropriate host cell, and recovering the immunogenic complexes from cell culture. The purification of these complexes is achieved through affinity chromatography. This innovative approach allows for the large-scale culturing of host cells, leading to the production of significant amounts of immunogenic complexes that can be utilized as a vaccine to elicit specific immune responses against cancer or infectious diseases.
Career Highlights
Julie Spielman is affiliated with the University of Miami, where she continues her research and development in the field of cancer immunotherapy. Her work has the potential to transform treatment options for patients suffering from cancer and infectious diseases.
Collaborations
Julie has collaborated with esteemed colleagues, including Eckhard R Podack and Koichi Yamazaki, to advance her research and contribute to the scientific community.
Conclusion
Julie Spielman's innovative work in cancer immunotherapy exemplifies the impact of scientific research on healthcare. Her patented methods for purifying immunogenic complexes represent a significant advancement in the fight against cancer and infectious diseases.
